• DOI:10.1182/BLOOD.V126.23.4092.4092
Corpus ID: 78298828

A Recombinant Antibody to Siglec-8 Shows Selective ADCC Activity Against Mast Cells from Systemic Mastocytosis Patients

@article{Falahati2015ARA,
  title={A Recombinant Antibody to Siglec-8 Shows Selective ADCC Activity Against Mast Cells from Systemic Mastocytosis Patients},
  author={Rustom Falahati and J. Bright and A. Dorenbaum and C. Bebbington and N. Toma{\vs}evi{\'c} and D. Lidke and T. George and J. Gotlib},
  journal={Blood},
  year={2015},
  volume={126},
  pages={4092-4092}
}

Rustom Falahati, J. Bright, +5 authors J. Gotlib

Published 2015

Medicine

Blood

Background: Systemic mastocytosis (SM) is a rare myeloproliferative neoplasm characterized by the accumulation of neoplastic mast cells (MC) in one or more extracutaneous organs. In all forms of SM, anti-mediator drugs are used to control symptoms of MC degranulation. In advanced forms of SM, organ damage is common and patients (pts) exhibit reduced life expectancy. In these individuals, cytoreductive agents such as cladribine and interferon-alpha have been used off-label, and inhibitors of KIT… CONTINUE READING

View via Publisher

doi.org

Save to Library

Create Alert

Cite

Launch Research Feed